Infusion Options, Inc. recalls METHOTREXATE 25 MG / 1 ML IM SYR; METHOTREXATE 12 mg QS 5 ml PF 0.9% NACL; METHOTREXATE 98 MG / 3.92 ML IM SYR; METHOTRE
Recalled August 21, 2019 · FDA recall D-1790-2019 · Infusion Options
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
NY only
Description
Lack of Assurance of Sterility
Product
METHOTREXATE 25 MG / 1 ML IM SYR; METHOTREXATE 12 mg QS 5 ml PF 0.9% NACL; METHOTREXATE 98 MG / 3.92 ML IM SYR; METHOTREXATE 55 MG / 2.2 ML IVP; METHOTREXATE 59.5 MG / 2.38 ML IVP; METHOTREXATE 12 mg QS 6 ml 0.9% NACL; METHOTREXATE 150 MG / 50 ML NS IVPB; METHOTREXATE 112.5 MG/ 4.5 ML IM SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
Manufacturer(s)
Infusion Options, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →